Vemurafenib
CAS 918504-65-1Small Molecule
Overview
Vemurafenib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1229517).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Vemurafenib expires 6 Jun 2032. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]propane-1-sulfonamide
- Canonical SMILES
- CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F
- InChIKey
- GPXBXXGIAQBQNI-UHFFFAOYSA-N
Verified Supplier Partner
Do you supply Vemurafenib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.